Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7901763, 12 pages
https://doi.org/10.1155/2017/7901763
Research Article

Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data

1Department of Biomedical Science and Human Oncology, Hygiene Section, University of Bari “Aldo Moro”, Bari, Italy
2Department of Biomedical Science and Human Oncology, General Pathology Section, University of Bari “Aldo Moro”, Bari, Italy
3Neonatology and NICU Section, Azienda Ospedaliero-Universitaria Policlinico of Bari, Bari, Italy
4Department of Biomedical Science and Human Oncology, Neonatology and NICU Section, University of Bari “Aldo Moro”, Bari, Italy

Correspondence should be addressed to Giuseppina Caggiano; ti.abinu@onaiggac.anippesuig

Received 16 March 2017; Accepted 18 June 2017; Published 13 August 2017

Academic Editor: Stanley Brul

Copyright © 2017 Giuseppina Caggiano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Testoni, M. Hayashi, M. Cohen-Wolkowiez et al., “Late-onset bloodstream infections in hospitalized term infants,” Pediatric Infectious Disease Journal, vol. 33, no. 9, pp. 920–923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Kelly, D. K. Benjamin, and P. B. Smith, “The epidemiology and diagnosis of invasive candidiasis among premature infants,” Clinics in perinatology, vol. 42, no. 1, pp. 17–105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Leibovitz, “Strategies for the prevention of neonatal candidiasis,” Pediatrics and Neonatology, vol. 53, no. 2, pp. 83–89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Caggiano, C. Coretti, N. Bartolomeo, G. Lovero, O. De Giglio, and M. T. Montagna, “Candida bloodstream infections in Italy: Changing epidemiology during 16 years of surveillance,” BioMed Research International, vol. 2015, Article ID 256580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Tavanti, A. D. Davidson, N. A. R. Gow, M. C. J. Maiden, and F. C. Odds, “Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III,” Journal of Clinical Microbiology, vol. 43, no. 1, pp. 284–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Borghi, R. Sciota, R. Iatta, C. Biassoni, M. T. Montagna, and G. Morace, “Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 30, no. 11, pp. 1437–1441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. Clinical and Laboratory Standards Institute, Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement, M27-S4, CLSI, Wayne, PA, USA, 2012.
  8. A. Espinel-Ingroff, M. A. Pfaller, B. Bustamante et al., “Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 4, pp. 2006–2012, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Pfaller, M. Castanheira, S. A. Messer, and R. N. Jones, “In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: Data from the SENTRY antifungal surveillance program, 2010 through 2012,” Mycoses, vol. 58, no. 4, pp. 209–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Presterl, F. Daxböck, W. Graninger, and B. Willinger, “Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria,” Clinical Microbiology and Infection, vol. 13, no. 11, pp. 1072–1076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Lagrou, J. Verhaegen, W. E. Peetermans, T. De Rijdt, J. Maertens, and E. Van Wijngaerden, “Fungemia at a tertiary care hospital: Incidence, therapy, and distribution and antifungal susceptibility of causative species,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 8, pp. 541–547, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Sarvikivi, O. Lyytikäinen, D. R. Soll et al., “Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit,” Journal of Clinical Microbiology, vol. 43, no. 6, pp. 2729–2735, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Spiliopoulou, G. Dimitriou, E. Jelastopulu, I. Giannakopoulos, E. D. Anastassiou, and M. Christofidou, “Neonatal Intensive Care Unit Candidemia: Epidemiology, Risk Factors, Outcome, and Critical Review of Published Case Series,” Mycopathologia, vol. 173, no. 4, pp. 219–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Lovero, O. De Giglio, O. Montagna et al., “Epidemiology of candidemia in neonatal intensive care units: A persistent public health problem,” Annali di Igiene, vol. 28, no. 4, pp. 282–287, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Montagna, G. Lovero, O. De Giglio, R. Iatta, G. Caggiano, O. Montagna et al., Journal of Preventive Medicine and Hygiene, vol. 51, 130, 125, 2010.
  16. A. M. Tortorano, A. Prigitano, C. Lazzarini et al., “A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade,” Infection, vol. 41, no. 3, pp. 655–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Rodriguez, B. Almirante, B. J. Park et al., “Candidemia in neonatal intensive care units: Barcelona, Spain,” Pediatric Infectious Disease Journal, vol. 25, no. 3, pp. 224–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Pemán, E. Cantón, M. J. Linares-Sicilia et al., “Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: A Spanish multicenter prospective survey,” Journal of Clinical Microbiology, vol. 49, no. 12, pp. 4158–4163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Yalaz, H. Çetin, M. Akisu, Ş. Aydemir, A. Tunger, and N. Kültürsay, “Neonatal nosocomial sepsis in a level-III NICU: Evaluation of the causative agents and antimicrobial susceptibilities,” Turkish Journal of Pediatrics, vol. 48, no. 1, pp. 13–18, 2006. View at Google Scholar · View at Scopus
  20. S. Celebi, M. Hacimustafaoglu, N. Koksal, H. Ozkan, M. Cetinkaya, and B. Ener, “Neonatal candidiasis: Results of an 8 year study,” Pediatrics International, vol. 54, no. 3, pp. 341–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Ozkan, M. Cetinkaya, N. Koksal, S. Celebi, and M. Hacimustafaoglu, “Culture-proven neonatal sepsis in preterm infants in a neonatal intensive care unit over a 7 year period: coagulase-negative Staphylococcus as the predominant pathogen,” Pediatrics International, vol. 56, no. 1, pp. 60–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Clerihew, T. L. Lamagni, P. Brocklehurst, and W. McGuire, “Invasive fungal infection in very low birthweight infants: National prospective surveillance study,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 91, no. 3, pp. F188–F192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Vergnano, E. Menson, N. Kennea et al., “Neonatal infections in England: The neonIN surveillance network,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 96, no. 1, pp. F9–F14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Aziz, A. L. Patel, J. Losavio et al., “Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants,” Pediatric Infectious Disease Journal, vol. 29, no. 4, pp. 352–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. K. N. Feja, F. Wu, K. Roberts et al., “Risk factors for candidemia in critically ill infants: a matched case-control study,” Journal of Pediatrics, vol. 147, no. 2, pp. 156–161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. L. Horn, D. Neofytos, E. J. Anaissie et al., “Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1695–1703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Pfaller, D. Neofytos, D. Diekema et al., “Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance) registry, 2004–2008,” Diagnostic Microbiology and Infectious Disease, vol. 74, no. 4, pp. 323–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Bizzarro, V. Shabanova, R. S. Baltimore, L.-M. Dembry, R. A. Ehrenkranz, and P. G. Gallagher, “Neonatal sepsis 2004-2013: The rise and fall of coagulase-negative staphylococci,” Journal of Pediatrics, vol. 166, no. 5, pp. 1193–1199, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Natarajan, M. Lulic-Botica, and J. V. Aranda, “Refractory neonatal candidemia and high-dose micafungin pharmacotherapy,” Journal of Perinatology, vol. 29, no. 11, pp. 738–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Robinson, H. D. Pham, B. T. Bloom, and R. R. Wittler, “Risk factors for persistent candidemia infection in a neonatal intensive care unit and its effect on mortality and length of hospitalization,” Journal of Perinatology, vol. 32, no. 8, pp. 621–625, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. G. C. M. Batista, V. L. J. Krebs, L. S. Ruiz, M. E. Auler, R. C. Hahn, and C. R. Paula, “Oral colonization: A possible source for candidemia in low-weight neonates,” Journal de Mycologie Medicale, vol. 24, no. 2, pp. 81–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. H. D. Hoffmann-Santos, C. R. Paula, A. C. A. Yamamoto, T. Tadano, and R. C. Hahn, “Six-Year Trend Analysis of Nosocomial Candidemia and Risk factors in Two Intensive Care Hospitals in Mato Grosso, Midwest Region of Brazil,” Mycopathologia, vol. 176, no. 5-6, pp. 409–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Cortés, P. Reyes, C. Gómez, G. Buitrago, and A. L. Leal, “Fungal bloodstream infections in tertiary care hospitals in Colombia,” Revista Iberoamericana de Micología, vol. 28, no. 2, pp. 74–78, 2011. View at Publisher · View at Google Scholar
  34. J. A. Cortés, P. Reyes, C. H. Gómez et al., “Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia,” Brazilian Journal of Infectious Diseases, vol. 18, no. 6, pp. 631–637, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Hua, J. Huang, Z. Wu, and Z. Feng, “A comparison study between Candida parapsilosis sepsis and Candida albicans sepsis in preterm infants,” Turkish Journal of Pediatrics, vol. 54, no. 5, pp. 502–508, 2012. View at Google Scholar · View at Scopus
  36. Z. Wu, Y. Liu, X. Feng et al., “Candidemia: Incidence rates, type of species, and risk factors at a tertiary care academic hospital in China,” International Journal of Infectious Diseases, vol. 22, pp. e4–e8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Chen, N. Chiu, H. Chi et al., “Changing of bloodstream infections in a medical center neonatal intensive care unit,” Journal of Microbiology, Immunology and Infection, 2015. View at Publisher · View at Google Scholar
  38. R. Rani, N. P. Mohapatra, G. Mehta, and V. S. Randhawa, “Changing trends of Candida species in neonatal septicaemia in a tertiary North Indian hospital,” Indian Journal of Medical Microbiology, pp. 2042–2044, 2002. View at Google Scholar
  39. J. Agarwal, S. Bansal, G. K. Malik, and A. Jain, “Trends in neonatal septicemia: Emergence of non-albicans Candida,” Indian Pediatrics, vol. 41, no. 7, pp. 712–715, 2004. View at Google Scholar · View at Scopus
  40. P. Femitha, R. Joy, B. Adhisivam et al., “Candidemia in neonatal ICU- experience from a tertiary care hospital,” Current Pediatric Research, vol. 17, no. 1, pp. 44–48, 2013. View at Google Scholar · View at Scopus
  41. V. Mehara, D. Yadava, P. Somania, G. Bhatambareb, S. Mulyea, and K. Singh, “Neonatal sepsis in a tertiary care center in central India: microbiological profile, antimicrobial sensitivity pattern and outcome,” Journal of Neonatal-Perinatal Medicine, vol. 6, pp. 165–172, 2013. View at Google Scholar
  42. D. Juyal, M. Sharma, S. Pal, V. K. Rathaur, and N. Sharma, “Emergence of non-albicans Candida species in neonatal candidemia,” North American Journal of Medical Sciences, vol. 5, no. 9, pp. 541–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Chaurasia, M. Goel, S. Dhruw, D. Dubey, and R. Dwivedi, “Changing Pattern of Neonatal Fungal Sepsis: A Matched Case – Control Study,” National Journal of Medical and Allied Sciences, vol. 4, no. 1, 2015, Online first. View at Google Scholar
  44. R. Wadile and V. Bhate, “Study of clinical spectrum and risk factors of neonatal candidemia,” Indian Journal of Pathology and Microbiology, vol. 58, no. 4, pp. 472–474, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Al-Sweih, Z. Khan, S. Khan, and L. V. Devarajan, “Neonatal candidaemia in Kuwait: A 12-year study of risk factors, species spectrum and antifungal susceptibility,” Mycoses, vol. 52, no. 6, pp. 518–523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Hammoud, A. Al-Taiar, M. Fouad, A. Raina, and Z. Khan, “Persistent candidemia in neonatal care units: Risk factors and clinical significance,” International Journal of Infectious Diseases, vol. 17, no. 8, pp. e624–e628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. E. A. Khan, S. Choudhry, M. Fatima, and Z. Batool, “Clinical spectrum, management and outcome of neonatal candidiasis,” Journal of the Pakistan Medical Association, vol. 65, pp. 1206–1209, 2015. View at Google Scholar
  48. J.-H. Wu, C.-Y. Chen, P.-N. Tsao, W.-S. Hsieh, and H.-C. Chou, “Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan,” Pediatrics & Neonatology, vol. 50, no. 3, pp. 88–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M.-H. Tsai, J.-F. Hsu, S.-M. Chu et al., “Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis,” Pediatric Infectious Disease Journal, vol. 33, no. 1, pp. e7–e13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. W. H. Lim, R. Lien, Y.-C. Huang et al., “Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants,” Pediatrics and Neonatology, vol. 53, no. 4, pp. 228–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. D. E. Ballot, N. Bosman, T. Nana, T. Ramdin, and P. A. Cooper, “Background changing patterns of neonatal fungal sepsis in a developing country,” Journal of Tropical Pediatrics, vol. 59, no. 6, Article ID fmt053, pp. 460–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Chen, M. Slavin, Q. Nguyen et al., “Active Surveillance of Candidemia, Australia,” Emerging Infectious Diseases, vol. 12, no. 10, pp. 1508–1516, 2006. View at Publisher · View at Google Scholar
  53. L. Clerihew, T. L. Lamagni, P. Brocklehurst, and W. McGuire, “Candida parapsilosis infection in very low birthweight infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 92, no. 2, pp. F127–F129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S.-K. Kim, K. El Bissati, and C. B. Mamoun, “Amino acids mediate colony and cell differentiation in the fungal pathogen Candida parapsilosis,” Microbiology, vol. 152, no. 10, pp. 2885–2894, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. A. A. Lattif, P. K. Mukherjee, J. Chandra et al., “Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis,” International Journal of Medical Microbiology, vol. 300, no. 4, pp. 265–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. P. G. Pappas, C. A. Kauffman, D. R. Andes, C. J. Clancy, K. A. Marr, L. Ostrosky-Zeichner et al., “Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America,” Clinical Infectious Diseases, vol. 62, pp. e1–50, 2016. View at Google Scholar
  57. L. P. Brion, S. E. Uko, and D. L. Goldman, “Risk of resistance associated with fluconazole prophylaxis: Systematic review,” Journal of Infection, vol. 54, no. 6, pp. 521–529, 2007. View at Publisher · View at Google Scholar · View at Scopus